From Botox to Boeing: Korean start-up Air Premia plans to fly Seoul-Los Angeles
Hugel made its name in Korea as a manufacturer of Botox, and now founder Hong Sung-Bum is the flagship investor in Korean start-up Air Premia, which will receive new Boeing 787-9 Dreamliners in 2020 and plans to fly between Seoul and Los Angeles in 2021. Regional Asia, Europe and Australia are also target markets. “The Los Angeles route has more demand than supply,” an Air Premia spokesperson said. Besides being a popular leisure destination for visiting Koreans, Los Angeles is home to the largest community of overseas Koreans and Korean-Americans, according to the Census Bureau. Non-stop seat capacity between Los Angeles and Seoul has decreased in recent years as Korean Air deployed smaller planes while SIA and THAI ended fifth freedom flights. <br/>
https://portal.staralliance.com/cms/news/hot-topics/2019-05-28/unaligned/from-botox-to-boeing-korean-start-up-air-premia-plans-to-fly-seoul-los-angeles
https://portal.staralliance.com/cms/logo.png
From Botox to Boeing: Korean start-up Air Premia plans to fly Seoul-Los Angeles
Hugel made its name in Korea as a manufacturer of Botox, and now founder Hong Sung-Bum is the flagship investor in Korean start-up Air Premia, which will receive new Boeing 787-9 Dreamliners in 2020 and plans to fly between Seoul and Los Angeles in 2021. Regional Asia, Europe and Australia are also target markets. “The Los Angeles route has more demand than supply,” an Air Premia spokesperson said. Besides being a popular leisure destination for visiting Koreans, Los Angeles is home to the largest community of overseas Koreans and Korean-Americans, according to the Census Bureau. Non-stop seat capacity between Los Angeles and Seoul has decreased in recent years as Korean Air deployed smaller planes while SIA and THAI ended fifth freedom flights. <br/>
